权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Characterization of Zif, a unique FemABX-like protein

Zif（一种独特的 FemABX 样蛋白）的表征

基本信息

批准号：
7408640
负责人：
GARY L SLOAN
金额：
$ 7.09万
依托单位：
UNIVERSITY OF ALABAMA IN TUSCALOOSA
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-05-01 至 2010-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7408640
关键词：
Acids Alanine Amino Acids Antibiotics Antimicrobial Resistance Bacteria Biological Assay Cell Wall Cephalosporins Complex Data Digestion Endopeptidases Enzymes Family member Gas Chromatography Genus staphylococcus High Pressure Liquid Chromatography Hydrolysis Immunity Intervention Knock-out Lysostaphin Modification Muramidase N-Acetylmuramoyl-L-alanine Amidase Numbers Object Attachment Organism Pathway interactions Penicillins Peptides Peptidoglycan Peptidyltransferase Process Protein Family Proteins Reaction Research Resistance Site Staphylococcus aureus Streptococcus Streptococcus equi Streptococcus zooepidemicus Structure System Testing antimicrobial drug bacteriocin base chemotherapeutic agent dimer enantiomer enzyme substrate expression vector interest lysostaphin endopeptidase lysyl endopeptidase member mutanolysin mutant polyglycine resistance factors synthetic peptide yeast two hybrid system

项目摘要

DESCRIPTION (provided by applicant): Our long-term objective is to define the mechanisms that allow some bacteria to modify their cell wall peptidoglycans (PGs) to become resistant to PG hydrolases, bacteriocins, and cell wall-targeted anti-microbials. In particular we are interested in FemABX-like immunity proteins, which modify PG cross bridges so that they become resistant to hydrolysis by bacteriolytic endopeptidases. In this project we will define the activity of the zoocin a immunity factor (Zif), a member of this family that is unique because it modifies PG without any apparent change in cross bridge composition. We will accomplish this through the following specific aims: 1) Define the site of action of zoocin A. Identification of the site of action of the enzyme will help identify the most likely target for Zif. First we will identify the products from the digestion of synthetic peptide substrates by the enzyme. Next, we will use HPLC/MS analysis of fragments generated from a zoocin A, mutanolysin digestion of purified PG of a zoocin A-negative, zoocin A-sensitive knockout mutant of Streptococcus equi subsp. zooepidemicus 4881, the zoocin A-producing organism, to confirm the bond or bonds hydrolyzed by zoocin A. 2) Determine the change in PG structure caused by Zif. Based on preliminary data, we hypothesize that Zif inserts D-alanine for L-alanine in PG cross bridges. First we will determine the ratio of D-alanine to L-alanine in PGs from zif+ and zif- strains. If our hypothesis is incorrect, comparison of HPLC/MS analyses of fragments from various digests of PGs from isogenic zif+ and zif- strains will be used to identify the change caused by Zif. 3) Determine if Zif forms complexes with other proteins. We will look for interactions between Zif and both MurM and MurN, which insert amino acids into streptococcal cross bridges during PG synthesis, and with other proteins using pulldowns. A bacterial two-hybrid system will also be used to look for interactions. Furthermore, Zif appears to be toxic in Staphylococcus aureus. Therefore we will determine if Zif forms complexes with FemA, FemB, or FemX, which insert amino acids into the staphylococcal cross bridges during PG synthesis, or with another FemABX-like immunity protein, Epr (also known as Lif), by pulldowns and with a bacterial two-hybrid system. The factors that are involved in cell wall synthesis are targets for a number of antibiotics, such as penicillins and cephalosporins, and alternative cell wall synthesis pathways are involved in resistance to these antimicrobial agents. This project will provide additional information regarding cell wall synthesis and degradation that may offer new targets for chemotherapeutic intervention.

描述（由申请方提供）：我们的长期目标是确定允许某些细菌修饰其细胞壁肽聚糖（PG）以耐PG水解酶、细菌素和细胞壁靶向抗微生物剂的机制。特别是，我们感兴趣的FemABX样免疫蛋白，修饰PG跨桥，使他们成为耐水解的溶菌内肽酶。在这个项目中，我们将定义动物霉素免疫因子（Zif）的活性，Zif是这个家族的一个成员，它是独一无二的，因为它修饰PG而没有任何明显的变化，在跨桥组成。我们将通过以下具体目标来实现这一目标：1）确定zoocin A的作用位点。确定酶的作用位点将有助于确定Zif最可能的靶点。首先，我们将鉴定酶消化合成肽底物的产物。接下来，我们将使用HPLC/MS分析从马链球菌亚种的动物霉素A、动物霉素A阴性的纯化PG的变溶素消化、动物霉素A敏感性敲除突变体产生的片段。Zoocin A产生生物zoocin micus 4881，以确认由zoocin A水解的一个或多个键。2)确定Zif引起的PG结构变化。基于初步数据，我们假设Zif在PG交叉桥中插入D-丙氨酸取代L-丙氨酸。首先，我们将确定来自zif+和zif-菌株的PG中D-丙氨酸与L-丙氨酸的比例。如果我们的假设是不正确的，则将使用来自同基因zif+和zif-菌株的PG的各种片段的HPLC/MS分析的比较来鉴定由Zif引起的变化。3)确定Zif是否与其他蛋白质形成复合物。我们将寻找Zif与MurM和MurN之间的相互作用，它们在PG合成过程中将氨基酸插入链球菌交叉桥，并使用下拉法与其他蛋白质相互作用。细菌双杂交系统也将用于寻找相互作用。此外，Zif似乎在金黄色葡萄球菌中有毒。因此，我们将确定Zif是否与FemA，FemB或FemX形成复合物，这些复合物在PG合成期间将氨基酸插入葡萄球菌交叉桥中，或者通过下拉和细菌双杂交系统与另一种FemABX样免疫蛋白Epr（也称为Lif）形成复合物。参与细胞壁合成的因子是许多抗生素的靶标，例如青霉素和头孢菌素，并且替代细胞壁合成途径参与对这些抗微生物剂的抗性。该项目将提供有关细胞壁合成和降解的额外信息，可能为化疗干预提供新的靶点。